1. Ambroxol, bromhexine: labelling updates endorsed in EU

   News item 14 March 2015 Pages: 1 - 1

2. Canada reviews use of VEGF receptor inhibitors and risk of TMA

   News item 14 March 2015 Pages: 2 - 2

3. Domperidone products withdrawn in Egypt

   News item 14 March 2015 Pages: 3 - 3

4. Japanese Relief System for ADRs

   News item 14 March 2015 Pages: 4 - 4

5. Label warnings required to stop sharing of insulin pens

   News item 14 March 2015 Pages: 5 - 5

6. Rienso: application for new indication withdrawn

   News item 14 March 2015 Pages: 6 - 6

7. Risk of errors with look-alike ampoules

   News item 14 March 2015 Pages: 7 - 7

8. ZENHALE lots recalled due to device malfunction

   News item 14 March 2015 Pages: 8 - 8

9. Heightened concerns regarding anaesthetic neurotoxicity

   Comment 14 March 2015 Pages: 9 - 9

10. NICE says involve patients in decision-making

    News item 14 March 2015 Pages: 10 - 10

11. Genetic factors in vincristine-related peripheral neuropathy

    Clinical study 14 March 2015 Pages: 11 - 11

12. Prothrombin complex concentrate safe for VKA reversal

    Clinical study 14 March 2015 Pages: 12 - 12

13. Testosterone therapy in men not linked to increased CV risks?

    Review 14 March 2015 Pages: 13 - 13

14. Acarbose/diazoxide

    Case report 14 March 2015 Pages: 14 - 14

15. Adalimumab/infliximab

    Case report 14 March 2015 Pages: 15 - 15

16. Adefovir

    Case report 14 March 2015 Pages: 16 - 16

17. Agomelatine

    Case report 14 March 2015 Pages: 17 - 17

18. Alendronic acid/ibandronic acid

    Case report 14 March 2015 Pages: 18 - 18

19. Alendronic acid/ibandronic acid/risedronic acid

    Case report 14 March 2015 Pages: 19 - 19

20. Alitretinoin

    Case report 14 March 2015 Pages: 20 - 20

21. Allopurinol

    Case report 14 March 2015 Pages: 21 - 21

22. Allopurinol

    Case report 14 March 2015 Pages: 22 - 22

23. Alprazolam/methadone

    Case report 14 March 2015 Pages: 23 - 23

24. Amikacin/clarithromycin/rifampicin

    Case report 14 March 2015 Pages: 24 - 24

25. Aminosalicylic acid/levofloxacin

    Case report 14 March 2015 Pages: 25 - 25

26. Amoxicillin

    Case report 14 March 2015 Pages: 26 - 26

27. Amoxicillin/ciprofloxacin/methotrexate interaction

    Case report 14 March 2015 Pages: 27 - 27

28. Amphotericin B/fluconazole/itraconazole

    Case report 14 March 2015 Pages: 28 - 28

29. Anakinra/hydroxychloroquine

    Case report 14 March 2015 Pages: 29 - 29

30. Antibacterials/antituberculars

    Case report 14 March 2015 Pages: 30 - 30

31. Antineoplastics

    Case report 14 March 2015 Pages: 31 - 31

32. Antineoplastics

    Case report 14 March 2015 Pages: 32 - 32

33. Antineoplastics

    Case report 14 March 2015 Pages: 33 - 33

34. Antineoplastics

    Case report 14 March 2015 Pages: 34 - 34

35. Antineoplastics/iodised oil

    Case report 14 March 2015 Pages: 35 - 35

36. Antineoplastics/methylprednisolone

    Case report 14 March 2015 Pages: 36 - 36

37. Antipsychotics

    Case report 14 March 2015 Pages: 37 - 37

38. Antiretrovirals

    Case report 14 March 2015 Pages: 38 - 38

39. Antithymocyte globulin/fludarabine/melphalan

    Case report 14 March 2015 Pages: 39 - 39

40. Aprepitant/cyclophosphamide interaction

    Case report 14 March 2015 Pages: 40 - 40

41. Aspirin

    Case report 14 March 2015 Pages: 41 - 41

42. Aspirin

    Case report 14 March 2015 Pages: 42 - 42

43. Aspirin/warfarin

    Case report 14 March 2015 Pages: 43 - 43

44. Batroxobin

    Case report 14 March 2015 Pages: 44 - 44

45. BCG

    Case report 14 March 2015 Pages: 45 - 45

46. BCG vaccine

    Case report 14 March 2015 Pages: 46 - 46

47. Beclometasone/methylprednisolone/prednisolone

    Case report 14 March 2015 Pages: 47 - 47

48. Bendamustine/rituximab

    Case report 14 March 2015 Pages: 48 - 48

49. Bevacizumab/paclitaxel

    Case report 14 March 2015 Pages: 49 - 49

50. Bevacizumab/yttrium-90

    Case report 14 March 2015 Pages: 50 - 50